Publications

The Vero cell line is the most used continuous cell line for viral vaccine manufacturing with more than 40 years of accumulated …

In 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease …

Abstract Every year, millions of people are infected by the influenza virus around the world, which results in more than half a million …

Lentiviral vectors (LVs) are a powerful tool for gene and cell therapy and human embryonic kidney cells (HEK293) have been extensively …

Abstract The Vero cell line is the most used continuous cell line in viral vaccine manufacturing. This adherent cell culture platform …

Removal of empty capsids from adeno-associated virus (AAV) manufacturing lots remains a critical step in the downstream processing of …

Vaccine design strategies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are focused on the Spike protein or its …

The Vero cell line is considered the most used continuous cell line for the production of viral vectors and vaccines. Historically, it …

Cell-derived influenza vaccines provide better protection and a host of other advantages compared to the egg-derived vaccines that …

The recombinant Vesicular Stomatitis Virus (rVSV) is an emerging platform for viral vector-based vaccines. Promising results have been …

Ebola virus disease outbreaks have repeatedly occurred on the African continent over the last decades, with more serious outbreaks in …

The production of lentiviral vectors (LVs) in human embryonic kidney 293 (HEK293) cells using serum-free medium in a suspension culture …

Immunotherapy with T cells expressing chimeric antigen receptors (CAR) is an emerging and promising treatment against refractory …

Ebola virus disease is an urgent international priority. Promising results for several vaccine candidates have been reported in …

Vero cells are considered as the most widely accepted continuous cell line by the regulatory authorities (such as WHO) for the …

One of the concerns associated with the use of influenza virus-like particles (VLPs) as vaccine candidate or delivery system is their …